Bank of Montreal
ADMA icon

Bank of Montreal’s ADMA Biologics ADMA Stock Holding History

Bank of Montreal’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,000
Closed -$730K – 3734
2025
Q4 		$730K Buy
+40,000
New +$674K ﹤0.01% 2138

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bank of Montreal's ADMA Position: Q1 2026 in Review

Bank of Montreal increased its ADMA Biologics (ADMA) stake by 10% in Q1 2026, buying an estimated $24K and bringing the position to 16,571 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #3025.

Bank of Montreal first reported a position in ADMA in Q2 2018 and has held it in 21 quarters since. The position peaked at $40.4M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Bank of Montreal held 16,571 shares of ADMA Biologics worth $149K as of Q1 2026.
  • Bank of Montreal bought 1,521 ADMA Biologics shares in Q1 2026, an estimated $24K.
  • ADMA Biologics made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #3025 holding.
  • Bank of Montreal first reported a position in ADMA Biologics in Q2 2018 and has held it in 21 quarters since.
  • Bank of Montreal's ADMA Biologics position peaked at $40.4M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.